This Modern Slavery and Human Trafficking Statement relates to actions and activities during the financial year 1st April 2017 to 31st Mar 2021. These actions and activities will continue to be in place unless regulations change or the Company feels the need to review it.
The statement sets down Lanset Medical Limited’s commitment to preventing slavery and human trafficking in our business activities and the steps we have put in place with the aim of ensuring that there is no slavery or human trafficking in our own business and supply chains. We all have a duty to be alert to risks, however small. Staff are expected to report their concerns and management to act upon them.
Organisational structure and supply chains
This statement covers the business activities of Lanset Medical Limited which are as follows:
Lanset Medical Limited is involved in marketing and distribution of innovative medical devices. All products are sourced ethically from various suppliers around the world.
Policies in relation to slavery and human trafficking
Lanset Medical Limited manages its business according to Modern Slavery Act 2015.
A copy is shared with all suppliers. This provides them with guidance about the prohibition of child labour and forced labour. Suppliers inside and outside Japan are also required to complete self-assessment questionnaires and attend training.
Lanset Medical asks all new suppliers to confirm whether they comply with the UK modern slavery act 2015 as part of the supplier registration process. A visit to the factory is part of the standard operating procedure to ascertain adherence to the act.
The following is the process by which the Company assesses whether activities or countries are high risk in relation to modern slavery or human trafficking. Most of the services Lanset procures are in highly skilled areas, where the risk of modern slavery practices is low. A supplier audit is conducted before signing the contract and modern slavery act 2015 questionnaire is sent to all suppliers every year to sign.
Responsibility for the Company’s anti-slavery initiatives is as follows:
- Policies, Risk assessments and Due diligence: As a small Company, currently MD has taken the responsibility for creating and reviewing policies. The process by which policies are developed is:- A. Physically visiting the manufacturing facilities before signing the contract. B. A questionnaire (attached above) is sent to the suppliers and get the form to sign them as confirmation of adherence to modern slavery act 2015 of the United Kingdom. As the Company grows, the task will be delegated to qualified employees.
To ensure a good understanding of the risks of modern slavery and human trafficking in our business and supply chains, the Company requires all current and future employees to undergo a training course which has been developed in line with Modern Slavery act 2015.
The Company is committed to ensuring that there is no modern slavery or human trafficking in our business or our supply chains. This Statement affirms its intention to act ethically in our business relationships.
The following policies set down our approach to the identification of modern slavery risks and steps to be taken to prevent slavery and human trafficking in our operations:
- Whistleblowing policy – the Company encourages all its workers, customers and other business partners to report any concerns related to its direct activities or its supply chains.
- Employee Code of Conduct – The Code of Conduct sets down the actions and behaviour expected of employees when representing the Company.
- Corporate Social Responsibility (CSR) Policy – The Company’s CSR policy summarises how we manage our environmental impacts and how we work responsibly with suppliers and local communities.
- Due Diligence Processes for Slavery and Human Trafficking
The Company undertakes due diligence when considering taking on new suppliers, and regularly reviews its existing suppliers. The Company’s due diligence process includes visiting their facility before signing the contract, sending out questionnaires yearly for them to sign and return and building long-standing relationships with them and evaluating the modern slavery and human trafficking risks of each new supplier.
The Company uses the following key performance indicators (KPIs) to measure how effective we are in ensuring slavery and human trafficking is not taking place in any part of our business or supply chains.
This Modern Slavery and Human Trafficking Statement will be regularly reviewed and updated as necessary. MD endorses this policy statement and is fully committed to its implementation.